.png){kind=logo}
Fundamentals
Select the financial statements you wish to view below. The reports below may be viewed on either an annual or quarterly basis.
NASDAQMMED
- Income Statement
- Annual
All numbers in thousands USD
Period Ending | Apr 30, 2026 | Apr 30, 2025 | ||
|---|---|---|---|---|
Total Revenue | 3,102,000 | 2,715,000 | ||
Cost of Revenue | (1,422,000) | 1,187,000 | ||
Gross Profit | 1,680,000 | 1,528,000 | ||
Operating Expenses | ||||
Research Development | (448,000) | 436,000 | ||
Selling General and Administrative | (1,183,000) | 1,245,000 | ||
Non Recurring | (18,000) | -- | ||
Others | (203,000) | (8,000) | ||
Total Operating Expenses | (1,852,000) | 1,673,000 | ||
Operating Income or Loss | (190,000) | (145,000) | ||
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | 1,000 | -- | ||
Earnings Before Interest And Taxes | (445,000) | (146,000) | ||
Interest Expense | -- | -- | ||
Income Before Tax | (189,000) | (146,000) | ||
Income Tax Expense | (128,000) | 52,000 | ||
Minority Interest | -- | -- | ||
Net Income From Continuing Ops | (317,000) | (198,000) | ||
Non-recurring Events | ||||
Discontinued Operations | -- | -- | ||
Extraordinary Items | -- | -- | ||
Effect Of Accounting Changes | -- | -- | ||
Other Items | (16,000) | (15,000) | ||
Net Income | (333,000) | (213,000) | ||
Preferred Stock And Other Adjustments | -- | -- | ||
Net Income Applicable To Common Shares | (333,000) | (213,000) | ||